Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Inflamm Bowel Dis

Search In Journal Title:

Abbravation: Inflammatory Bowel Diseases

Search In Journal Abbravation:

Publisher

Narnia

Search In Publisher:

DOI

10.1016/j.arthro.2005.08.030

Search In DOI:

ISSN

1078-0998

Search In ISSN:
Search In Title Of Papers:

Potential Oncogenic Properties of Mobilized Stem C

Authors: Kapetanakis Nikolaos Kountouras Jannis Zavos Christos Anastasiadou Kyriaki Tsarouchas George Michael Stavros Gavalas Emmanuel Tsiaousi Elena Polyzos Stergios A Venizelos Ioannis Nikolaidou Christina Vardaka Elizabeth
Publish Date: 2013/02/01
Volume: 19, Issue: 2, Pages: E27-E29
PDF Link

Abstract

Nikolaos Kapetanakis Jannis Kountouras Christos Zavos Kyriaki Anastasiadou George Tsarouchas Stavros Michael Emmanuel Gavalas Elena Tsiaousi Stergios A Polyzos Ioannis Venizelos Christina Nikolaidou Elizabeth Vardaka Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori Inflammatory Bowel Diseases Volume 19 Issue 2 1 February 2013 Pages E27–E29 https//doiorg/101002/ibd22911Marlicz et al1 concluded that Crohns disease CD triggers the mobilization of various types of stem cells such as hematopoietic stem progenitor cells into peripheral blood in patients suffering from this disease while the significance and precise role of these mobilized cells in repair of damaged intestine requires further study However the authors did not discuss the possibility of potential oncogenic properties of the mobilized stem cells at least in the subgroup of patients possibly infected with Helicobacter pylori H pyloriIn this regard although relative data indicate an absence or inverse association between H pylori and inflammatory bowel disease IBD the prevalence of H pylori infection in the IBD patients appears to be 382–47 in Europe2 Moreover enterohepatic and gastric Helicobacter species have been documented in fecal specimens from children with CD using polymerase

Keywords:

References

citation title=In situ H pylori infection and oncogenes expression in patients with colorectal cancer citation journal title=Gut citation year=2004 citation volume=53 citation pages=A270

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Gender and Location of CRC in IBDImplications for Surveillance Protocols
  2. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent
  3. Targeting TNF in Postoperative Recurrence of Crohn's Disease:Can We Extinguish the Fire Before It Starts?
  4. Gene Expression Profiling Identifies Mechanisms of Protection to Recurrent Trinitrobenzene Sulfonic Acid Colitis Mediated by Probiotics
  5. Adalimumab Therapy in Crohn's Disease of the Ileal Pouch
  6. Observations on Severity and Activity Indices in a Therapeutic Trial of Active Crohn's Disease
  7. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
  8. One-year Investigator-blind Randomized Multicenter Trial Comparing Asacol 2.4 g Once Daily with 800 mg Three Times Daily for Maintenance of Remission in Ulcerative Colitis
  9. Role of diet in the development of inflammatory bowel disease
  10. Thromboembolism in pediatric inflammatory bowel disease: Systematic review
  11. Potential Oncogenic Properties of Mobilized Stem Cells in a Subpopulation of Inflammatory Bowel Disease Patients Infected with Helicobacter pylori
  12. Twin Studies Reveal Specific Imbalances in the Mucosaassociated Microbiota of Patients with Ileal Crohn's Disease
  13. Microbial Causation of the Chronic Idiopathic Inflammatory Bowel Diseases
  14. Babesiosis in a Patient on Infliximab for Crohn's Disease
  15. Plasma Chromogranin A in Patients With Inflammatory Bowel Disease: A Possible Explanation
  16. Effect of Adalimumab on Clinical Laboratory Parameters in Patients with Crohn's Disease: Results from the CHARM Trial
  17. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease
  18. What is the incidence, prevalence, and natural history of indeterminate colitis?
  19. Anti-tumor Necrosis Factor and Postoperative Complications in Crohn's Disease: Systematic Review and Meta-analysis
  20. Effects of T cell-induced colonic inflammation on epithelial barrier function†
  21. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients
  22. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis
  23. Dangers associated with endoscopic management of strictures in IBD
  24. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease†
  25. Role of the interleukin 24 in patients with ulcerative colitis
  26. Antibodies Against Cyclic Citrullinated Peptide (CCP) in Inflammatory Bowel Disease Patients With or Without Arthritic Manifestations
  27. Nitric Oxide and Colitis: Rats, Humans and Now Macaques
  28. Distinct Microbiome in Pouchitis Compared to Healthy Pouches in Ulcerative Colitis and Familial Adenomatous Polyposis
  29. Is Crohn's creeping fat an adipose tissue?
  30. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease
  31. Cyclosporine in the management of severe ulcerative colitis while breast-feeding
  32. Nailing down the shingles in IBD
  33. Local Injection of Infliximab in Symptomatic Isolated Mucosal LesionsA Novel Scenario for Endoscopic Therapy?
  34. A New Type of Strictureplasty for the Treatment of Multiple Long Stenosis in Crohn's Disease
Search Result: